Sight Sciences (NASDAQ: SGHT) CFO sells 7,231 shares to cover RSU taxes

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Sight Sciences, Inc. Chief Financial Officer James Rodberg reported an open-market sale of 7,231 shares of common stock on April 6, 2026 at a weighted average price of $3.55 per share. According to the disclosure, the shares were sold to cover his tax liability tied to recently vesting restricted stock units.

Following this tax-related sale, Rodberg directly holds a total of 230,939 shares of common stock, including 47,160 currently held shares and 183,779 additional shares that will be acquired upon future vesting and settlement of restricted stock units. The transaction represents a small portion of his overall equity position.

Insider Trade Summary 10b5-1

Net Seller: 7,231 shares ($25,670)

Net Sell 1 txn

Insider Rodberg James

Role Chief Financial Officer

Sold 7,231 shs ($26K)

Type	Security	Shares	Price	Value
Sale	Common Stock	7,231	$3.55	$26K

Holdings After Transaction: Common Stock — 230,939 shares (Direct)

Footnotes (1)

Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 47,160 shares of Common Stock, and (ii) 183,779 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 7,231 shares Weighted average sale price: $3.55 per share Sale price range: $3.43–$3.58 per share +3 more

6 metrics

Shares sold 7,231 shares Open-market sale on April 6, 2026

Weighted average sale price $3.55 per share Common stock sale to cover tax liability

Sale price range $3.43–$3.58 per share Multiple transactions within this range

Shares held after transaction 230,939 shares Direct holdings following April 6, 2026 sale

Currently held common stock 47,160 shares Portion of total holdings not tied to unvested RSUs

Unvested RSU-related shares 183,779 shares To be acquired upon future RSU vesting and settlement

Key Terms

restricted stock units, weighted average price, open-market sale, tax liability

4 terms

restricted stock units financial

"in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

tax liability financial

"sold to cover the Reporting Person's tax liability in connection with the vesting"

Form 4 Insider Transactions: What Each Field Means →

04/09/2026 - 05:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rodberg James

(Last)

(First)

(Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK

CALIFORNIA

94025

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/06/2026		S		7,231⁽¹⁾	D	$3.55⁽²⁾	230,939⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 47,160 shares of Common Stock, and (ii) 183,779 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for James Rodberg	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Sight Sciences (SGHT) report for its CFO?

Sight Sciences reported that CFO James Rodberg sold 7,231 shares of common stock on April 6, 2026. The weighted average sale price was $3.55 per share, and the sale was made specifically to cover his tax liability from recently vesting restricted stock units.

At what prices did the Sight Sciences (SGHT) CFO sell his shares?

The CFO’s 7,231 Sight Sciences shares were sold at a weighted average price of $3.55 per share. The disclosure notes multiple trades occurred in a price range from $3.43 to $3.58 inclusive, reflecting normal execution across several individual transactions that same day.

Why did the Sight Sciences (SGHT) CFO sell 7,231 shares?

The CFO’s sale of 7,231 Sight Sciences shares was carried out to cover his tax liability arising from the vesting of restricted stock units. This type of sale is typically administrative, helping the insider satisfy tax obligations associated with equity-based compensation awards.

How many Sight Sciences (SGHT) shares does the CFO hold after the sale?

After the April 6, 2026 sale, CFO James Rodberg directly holds 230,939 shares of Sight Sciences common stock. This total includes 47,160 currently owned shares and 183,779 additional shares that are scheduled to be received as his existing restricted stock units vest over time.

Is the Sight Sciences (SGHT) CFO’s sale a large portion of his holdings?

The CFO sold 7,231 shares while retaining 230,939 shares in total, so the transaction represents only a small fraction of his disclosed equity position. Given the stated purpose of covering tax liabilities, it appears to be a routine compensation-related sale rather than a major ownership reduction.

What type of security was involved in the Sight Sciences (SGHT) insider sale?

The transaction involved Sight Sciences common stock with a par value of $0.001 per share. The sale was an open-market transaction used to cover tax obligations linked to vesting restricted stock units, a common equity-based compensation tool for senior executives.